ArticleDementia & neuropsychologia2026
The modified Rowland Universal Dementia Assessment Scale for dementia screening in the Peruvian population.
Article in Dementia & neuropsychologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dementia cases are rising globally, particularly in low- and middle-income countries like those in Latin America. Objective: The aim of the study was to enhance diagnostic accuracy in diverse populations; modifications to brief cognitive tools may be necessary. Methods: This cross-sectional study involved 197 participants who underwent neurocognitive assessments with both the Peruvian version of the Rowland Universal Dementia Assessment Scale (RUDAS-PE) and a modified version of RUDAS-PE (mRUDAS-PE). Statistical analyses, including chi-square tests and receiver-operator curves, were used to compare the diagnostic performance of the original and modified RUDAS. Results: The mRUDAS-PE showed improved performance in the visuospatial construction domain, with more participants achieving top scores, especially among controls and Alzheimer's disease patients. The judgment domain also yielded higher scores for controls. Only the judgment domain modifications do not change the diagnostic accuracy. Conclusion: Judgment modifications could be considered to improve the diagnostic performance of RUDAS-PE. Further testing in populations with different educational levels from rural areas is needed to assess their broader impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.